ALOPECIA AREATA
Clinical trials for ALOPECIA AREATA explained in plain language.
Never miss a new study
Get alerted when new ALOPECIA AREATA trials appear
Sign up with your email to follow new studies for ALOPECIA AREATA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hair loss: vitamin d cream vs steroid shots in Head-to-Head trial
Disease control Not yet recruitingThis study compares a vitamin D-based cream (calcipotriol) to steroid injections for treating patchy hair loss caused by alopecia areata, an autoimmune condition. Sixty adults with less than half of their scalp affected will receive one of the two treatments for 12 weeks. The goa…
Matched conditions: ALOPECIA AREATA
Phase: PHASE4 • Sponsor: Hayat Abad Medical Complex, Peshawar • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
New hope for severe hair loss: drug showdown begins
Disease control Not yet recruitingThis study tests two pills—tofacitinib and methotrexate—against each other in 78 adults with severe alopecia areata, including total scalp and body hair loss. Participants take one of the medicines for 12 weeks, and doctors measure hair regrowth using a standard scoring tool. The…
Matched conditions: ALOPECIA AREATA
Phase: PHASE4 • Sponsor: Hayat Abad Medical Complex, Peshawar • Aim: Disease control
Last updated May 17, 2026 06:43 UTC
-
Hair loss showdown: methotrexate gel vs minoxidil spray in new trial
Disease control Not yet recruitingThis study tests whether a methotrexate gel applied to the scalp can regrow hair better than the standard minoxidil spray in people with patchy alopecia areata. About 268 adults with less than 25% scalp hair loss will use one of the treatments for 24 weeks. The goal is to see whi…
Matched conditions: ALOPECIA AREATA
Phase: PHASE4 • Sponsor: Jinnah Postgraduate Medical Centre • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Italian skin disease registry aims to map Real-World treatment patterns
Knowledge-focused Not yet recruitingThis study will look at existing medical records from 20,000 people aged 12 and older in Italy who have psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa. Researchers want to learn about the types of treatments patients receive, how their diseas…
Matched conditions: ALOPECIA AREATA
Sponsor: Fondazione ISIDE • Aim: Knowledge-focused
Last updated May 17, 2026 06:45 UTC